GLIOBLASTOMA MULTIFORME (GBM)

Clinical trials for GLIOBLASTOMA MULTIFORME (GBM) explained in plain language.

Never miss a new study

Get alerted when new GLIOBLASTOMA MULTIFORME (GBM) trials appear

Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME (GBM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for kids with tough cancers: testing a powerful drug duo

Disease control Ongoing

This study is testing a new combination of two drugs, cobolimab and dostarlimab, for children and young adults with advanced solid tumors that have not responded to other treatments. The main goals are to find the safest and most effective dose and to see how well the body tolera…

Matched conditions: GLIOBLASTOMA MULTIFORME (GBM)

Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

GLIOBLASTOMA MULTIFORME (GBM)

Get alerted when new GLIOBLASTOMA MULTIFORME (GBM) trials appear

New hope for kids with tough cancers: testing a powerful drug duo